Karolinska Development announces that portfolio company OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, has entered new commercial partnerships covering distribution of its products in Italy, Spain, Switzerland, Austria and The Netherlands.
OssDsign’s lead products – OSSDSIGN Cranial and OSSDSIGN Facial – are already on sale in Germany, the UK and the Nordic region, as well as selected non-European markets including Singapore and Israel. The company is preparing for its first product launch in the US, which is anticipated during the first quarter of 2017, and is also undertaking regulatory and commercial activities in Japan.
OssDsign commercial strategy is focused on building sales of its innovative products through a combination of internal sales organisation and distribution partnerships.
Anders Lundqvist, CEO of OssDsign, said: “We are very pleased to increase our commercial footprint in Europe as we work to become the leading provider of regenerative implants for cranial and facial reconstruction. We now have experienced and well-motivated teams in place in order to execute our European strategy and bring OssDsign products closer to the surgeons and patients who will ultimately benefit from them.”
Viktor Drvota, Chief Investment Officer at Karolinska Development, said: “These partnerships are positive news for OssDsign, as the Company continues to execute its commercial strategy and drive sales of its innovative product around the world.”
